Skip to main content
    O

    Oramed Pharmaceuticals Inc (ORMP)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.18
    +0.04 (+0.97%)

    Market Cap: $172.21M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    66%(25/38)
    Avg Surprise
    +48.89%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.43
    Range$0.43 - $0.43
    1 analysts
    EPS Revisions
    1
    0
    7d
    No revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.00n/a
    60d ago$0.52-17.3%
    30d ago$0.52-17.3%
    7d ago$0.52-17.3%
    Current$0.43
    Revenue Consensus
    $0
    Range$0 - $0
    1 analysts
    Period ending Dec 31, 2026
    EPS Consensus$3.61
    Range$3.61 - $3.61
    1 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$3.61---
    Sep 26EST
    		-$0.43---
    Jun 26
    Reported Aug 10
    		$-0.09N/A-120.93%Miss-129.0%
    Mar 26
    Reported May 19
    		$0.91N/AN/ABeat+580.4%
    Dec 25
    Reported Mar 26
    		$0.25$-0.08+412.50%Beat+198.0%
    Sep 25
    Reported Nov 13
    		$1.13$-0.04+2925.00%Beat+335.4%
    Jun 25
    Reported Aug 14
    		$0.31$-0.04+875.00%Beat+40.9%
    Mar 25
    Reported May 15
    		$-0.19$-0.03-533.33%Miss-575.0%
    Dec 24
    Reported Mar 27
    		$-0.26$0.02-1376.00%Miss-177.3%
    Sep 24
    Reported Nov 7
    		$-0.48$-0.02-2300.00%Miss-500.0%
    Jun 24
    Reported Aug 14
    		$0.22$-0.02+1200.00%Beat+833.3%
    Mar 24
    Reported May 9
    		$0.04$0.02+100.00%Beat+150.0%
    Dec 23
    Reported Mar 6
    		$0.33$-0.12+375.00%Beat+250.0%
    Sep 23
    Reported Nov 9
    		$-0.08$-0.09+11.11%Beat+55.6%
    Jun 23
    Reported Aug 10
    		$-0.03N/A+66.67%Beat+88.9%
    Mar 23
    Reported May 11
    		$-0.08N/A+68.00%Beat+70.4%
    Dec 22
    Reported Mar 6
    		$-0.22$-0.23+4.35%Beat+0.0%
    Sep 22
    Reported Nov 10
    		$-0.18$-0.26+30.77%Beat+14.3%
    Jun 22
    Reported Aug 10
    		$-0.27$-0.24-12.50%Miss-58.8%
    Mar 22
    Reported May 12
    		$-0.27$-0.27+0.00%Beat-58.8%
    Dec 21
    Reported Jan 11
    		$-0.22$-0.16-37.50%Miss+4.3%
    Sep 21
    Reported Nov 24
    		$-0.21$-0.18-16.67%Miss-75.0%
    Jun 21
    Reported Jul 14
    		$-0.17$-0.24+29.17%Beat-70.0%
    Mar 21
    Reported Apr 13
    		$-0.17$-0.17+0.00%Beat+19.0%
    Dec 20
    Reported Jan 14
    		$-0.23$-0.19-21.05%Miss-53.3%
    Sep 20
    Reported Nov 24
    		$-0.12$-0.21+42.86%Beat+7.7%
    Jun 20
    Reported Jul 7
    		$-0.10$-0.20+50.00%Beat+56.5%
    Mar 20
    Reported Apr 6
    		$-0.21$-0.17-23.53%Miss+0.0%
    Dec 19
    Reported Jan 9
    		$-0.15$-0.23+34.78%Beat+40.0%
    Sep 19
    Reported Nov 27
    		$-0.13$-0.24+45.83%Beat+27.8%
    Jun 19
    Reported Jul 10
    		$-0.23$-0.24+4.17%Beat+23.3%
    Mar 19
    Reported Apr 10
    		$-0.21$-0.26+19.23%Beat-5.0%
    Dec 18
    Reported Jan 14
    		$-0.25$-0.19-31.58%Miss-38.9%
    Sep 18
    Reported Nov 28
    		$-0.18$-0.29+37.93%Beat+10.0%
    Jun 18
    Reported Jul 12
    		$-0.30$-0.27-11.11%Miss-100.0%
    Mar 18
    Reported Apr 8
    		$-0.20$-0.29+31.03%Beat+16.7%
    Dec 17
    Reported Jan 11
    		$-0.18$-0.21+14.29%Beat+10.0%
    Sep 17
    Reported Nov 29
    		$-0.20$-0.23+13.04%Beat-
    Jun 17
    Reported Jul 6
    		$-0.15$-0.27+44.44%Beat-
    Mar 17
    Reported Apr 5
    		$-0.24$-0.19-26.32%Miss-
    Dec 16
    Reported Jan 11
    		$-0.20$-0.12-66.67%Miss-

    Dividends

    Dividend Metrics

    Forward Yield5.98%
    Forward Annual Dividend$0.25
    Payout Ratio6.08%
    Pay MonthsJan

    Key Metrics

    Valuation
    P/E Ratio1.90EV/EBITDAN/A
    Price/FCF-30.75xFCF Yield-3.25%
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE74.20%ROICN/A
    Financial Health
    Debt/EquityN/AInterest Coverage1.99x
    Current Ratio4.98xQuick Ratio4.98x
    Trading Statistics
    Beta1.28Avg Volume169.55K
    52-Week High$5.4752-Week Low$1.95

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$4.31
    SMA 20$4.50
    SMA 50$4.64
    SMA 200$3.97
    EMA 10$4.30
    EMA 20$4.43
    EMA 50$4.51
    EMA 200$3.96

    MACD

    Line: -0.14Signal: -0.10Hist: -0.04

    ADX

    ADX: 26.5+DI: 11.7-DI: 25.1

    Aroon & PSAR

    Aroon Up44.0
    Aroon Down96.0
    PSAR$4.46

    Bollinger Bands

    Upper Band$4.97
    Lower Band$4.04
    %B Position2057%(Upper)
    Band Width0.15

    RSI (14-Day)

    Neutral
    34.7

    Momentum Oscillators

    Stoch %K4.9
    Stoch %D8.9
    Williams %R-91.1
    ROC (10d)-6.7%
    Momentum-0.30
    CCI (20d)-105.4
    MFI (14d)24.7

    Volatility Measures

    ATR (14d)$0.16(3.9%)
    StdDev (20d)0.23
    Hist Vol30.6%(Moderate)

    Volume Flow

    VWAP$4.20
    OBV3.5M
    AD Line-60.7M
    CMF (20d)-0.095

    Volume Metrics

    Avg Vol (20d)174.0K
    Vol Ratio0.7x
    VWMA (20d)$4.55

    Pivot Points

    R3$4.30
    R2$4.26
    R1$4.20
    Pivot Point$4.16
    S1$4.10
    S2$4.06
    S3$4.00

    Advanced Oscillators

    TSI-25.75
    Ultimate Osc38.3
    KST-88.38

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$2.00M$0$0$0$0$0$0
    Cost of Revenue$0$30,000$30,000$31,000$30,000$1.99M$31,000$0$0$0$53,000N/A
    Gross Profit$0$-30,000$-30,000$-31,000$-30,000$13,000$-31,000$-52,000$-54,000$-56,000$-53,000N/A
    Operating Expenses$2.77M$3.66M$5.64M$2.40M$2.49M$4.51M$3.56M$3.09M$3.13M$2.96M$3.82M$2.89M
    R&D$0$1.59M$1.99M$1.15M$1.03M$2.21M$1.46M$2.24M$1.44M$1.18M$1.71M$957,000
    SG&A$2.77M$2.06M$3.68M$1.27M$1.46M$2.31M$2.13M$847,000$1.69M$1.78M$2.11M$2.60M
    Operating Income$-2,766,000$-3,659,000$-5,672,000$-2,427,000$-2,489,000$-4,500,000$-3,595,000$-3,089,000$-3,135,000$-2,962,000$-3,877,000$-2,893,000
    Interest Income$103.74M$276,000$0$0$15.37M$647,000$1.10M$0$14.23M$5.09M$3.52M$435,000
    Interest Expense$0$0$337,000$0$0$2.56M$15.42M$15.42M$261,000$592,000$1.21M$826,000
    Income Before Tax$101.59M$49.44M$9.80M$59.45M$13.13M$-7,058,000$-9,783,000$-18,509,000$10.84M$1.53M$13.30M$-3,284,000
    Income Tax Expense$23.43M$11.13M$-212,000$11.06M$-126,000$584,000$416,000$1.13M$1.63M$0$0$373,000
    Net Income$78.16M$38.31M$10.01M$48.40M$13.29M$-7,642,000$-10,189,000$-19,619,000$9.21M$1.54M$13.34M$-3,222,000
    EBITDA$101.62M$-3,629,000$-5,642,000$59.48M$13.16M$-4,470,000$-3,564,000$-18,457,000$11.15M$2.18M$-3,824,000$-2,404,000
    EBIT$101.59M$-3,659,000$-5,672,000$59.45M$13.13M$-4,500,000$-3,595,000$-18,509,000$11.10M$2.13M$-3,877,000$-2,458,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about ORMP

    News

    Oramed Pharmaceuticals schedules November 12 results for Oramed Pharmaceuticals stock

    Oramed Pharmaceuticals is scheduled to report its next quarterly results on November 12, 2026. The stock's P/E ratio was 1.01 and its market capitalization was USD 173.5 million as of October 15...

    ad-hoc-news.de•10/15/26•Neutral

    Oramed Pharmaceuticals stock fell 3.74 percent as targets rose

    Oramed Pharmaceuticals stock dropped 3.74% to USD 4.38 on Nasdaq, falling below the average analyst target of USD 7.14, which Fintel recently raised. Despite the stock decline...

    AD HOC NEWS•10/7/26•Somewhat-Bearish

    Oramed Pharmaceuticals Inc (OJU1.DU) stock price, news, quote and history

    This page provides an overview of Oramed Pharmaceuticals Inc (OJU1.DU) stock, including its current price, a summary, news, charts, and historical data. As of the latest update, OJU1.DU is trading at 3.8300 EUR...

    Yahoo Finance Australia•10/4/26•Neutral

    Oramed Pharmaceuticals stock trades at USD 4.49 after insider sale

    Oramed Pharmaceuticals (ORMP) stock is trading at $4.49 after recent insider sales, including 30,000 shares sold by the COO and 20,000 by the CFO...

    AD HOC NEWS•10/4/26•Somewhat-Bearish

    Under a trading plan, Oramed (ORMP) COO Joshua Hexter sells 30,000 shares at $4.511 on average.

    Oramed Pharmaceuticals' COO & CBO, Joshua Hexter, sold 30,000 shares of ORMP on October 1, 2026, at a weighted average price of $4.511 per share. This sale was conducted under a Rule 10b5-1 trading plan adopted on March...

    Stock Titan•10/2/26•Somewhat-Bearish

    ORMP Valuation and Fair Value

    P/E
    1.9x
    P/FCF
    -30.8x
    PEG
    0.0x
    P/B
    0.6x
    See GNG's fair value

    ORMP Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    74.2%
    FCF yield
    -3.3%

    ORMP Competitors

    CompanyTicker
    Sutro BiopharmaSTRO
    Whitehawk Therapeutics, Inc.WHWK
    Invivyd Inc.IVVD
    Precision BioSciences IncDTIL
    Sionna Therapeutics, Inc. Common StockSION
    Coherus BioSciences IncCHRS
    Sharps Technology IncSTSS
    Innate PharmaIPHA

    Sector: Healthcare

    ORMP Bull Case vs Bear Case

    Bear case

    • ORMP's quarterly revenue changed -100.0% year over year.

    ORMP Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    135.3%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $0.43
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 0 down

    ORMP Dividend

    Forward yield
    6.0%
    Payout ratio
    6.1%
    Pay months
    Jan

    Frequently Asked Questions About ORMP

    What is ORMP's current dividend yield?

    Oramed Pharmaceuticals Inc (ORMP) has a forward dividend yield of 5.98%.

    Does ORMP pay dividends?

    Yes, Oramed Pharmaceuticals Inc pays dividends with a forward dividend yield of 5.98%.

    What is ORMP's P/E ratio?

    Oramed Pharmaceuticals Inc has a price-to-earnings (P/E) ratio of 1.90.

    What is ORMP's market cap?

    Oramed Pharmaceuticals Inc (ORMP) has a market capitalization of $172.21M with a current stock price of $4.18.

    Related stocks

    Sector: Healthcare

    All stocks starting with O

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In